Annovis Bio Inc
(ANVS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||
| Net Income | -536 | -191 | -714 |
| Depreciation Amortization | 2 | 1 | 0 |
| Accounts payable and accrued liabilities | -68 | -58 | N/A |
| Other Working Capital | 119 | -47 | 73 |
| Other Operating Activity | 104 | 67 | 83 |
| Operating Cash Flow | $-379 | $-229 | $-559 |
| Cash Flows From Investing Activities | |||
| Investing Cash Flow | $N/A | $N/A | $0 |
| Cash Flows From Financing Activities | |||
| Debt Issued | N/A | 530 | N/A |
| Other Financing Activity | 449 | 0 | 246 |
| Financing Cash Flow | $449 | $530 | $246 |
| Beginning Cash Position | 35 | 35 | 347 |
| End Cash Position | 105 | 337 | 35 |
| Net Cash Flow | $69 | $301 | $-312 |
| Free Cash Flow | |||
| Operating Cash Flow | -379 | -229 | -559 |
| Free Cash Flow | -379 | -229 | -559 |